Apyx Medical Corporation
APYX
NASDAQ·Healthcare·Medical - Specialties·Mkt cap $128.4M
$3.05
▼ -0.33%
P/E
-15.27
Mkt Cap
$128.4M
52-Wk Range
$1.70–$5.08
52-Week Range
$1.70 - $5.08
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 48.1% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary helium plasma technology with limited direct competition
- Established brand recognition in cosmetic and surgical markets
- Recurring revenue model from consumable hand pieces and accessories
- Diversified customer base across cosmetic surgeons, plastic surgeons, and hospitals
Bear Case
1 risk
- Average volatility.
Growth
Stable outlook
Expanding global demand for minimally invasive cosmetic procedures
Value
Deep value opportunity - significant discount to Medical Devices peers
Momentum
Falling
-36.1% over 3m
Quality
Stable
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying APYX right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 5, 2026
AUG 6, 2026
Reported EPS of -$0.07 vs -$0.08 consensus (+14.6% surprise). Revenue of $13.9M vs $13.2M expected (+5.4%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+14.6%
Revenue trend · last 8Q
—
—
-8%
-6%
+12%
+35%
+32%
+18%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$11.5M
$14.2M
$9.4M
$11.4M
$12.9M
$19.2M
$12.5M
$13.4M
Margins · last 8Q
Gross
90.5%
Operating
-13.5%
Profit
-24.2%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: HC Wainwright · Jul 13, 2026
vs Industry
How APYX stacks vs Medical - Specialties
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related